JP2023155262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023155262A5 JP2023155262A5 JP2023127717A JP2023127717A JP2023155262A5 JP 2023155262 A5 JP2023155262 A5 JP 2023155262A5 JP 2023127717 A JP2023127717 A JP 2023127717A JP 2023127717 A JP2023127717 A JP 2023127717A JP 2023155262 A5 JP2023155262 A5 JP 2023155262A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- set forth
- sequence set
- adc
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571246P | 2017-10-11 | 2017-10-11 | |
| US62/571,246 | 2017-10-11 | ||
| JP2020542037A JP7379347B2 (ja) | 2017-10-11 | 2018-10-11 | プレクチン１結合抗体およびその使用 |
| PCT/US2018/055438 WO2019075216A1 (en) | 2017-10-11 | 2018-10-11 | ANTIBODIES BINDING TO PELTIN-1 AND USES THEREOF |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542037A Division JP7379347B2 (ja) | 2017-10-11 | 2018-10-11 | プレクチン１結合抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023155262A JP2023155262A (ja) | 2023-10-20 |
| JP2023155262A5 true JP2023155262A5 (https=) | 2024-03-06 |
Family
ID=66101714
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542037A Active JP7379347B2 (ja) | 2017-10-11 | 2018-10-11 | プレクチン１結合抗体およびその使用 |
| JP2023127717A Pending JP2023155262A (ja) | 2017-10-11 | 2023-08-04 | プレクチン１結合抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542037A Active JP7379347B2 (ja) | 2017-10-11 | 2018-10-11 | プレクチン１結合抗体およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12053530B2 (https=) |
| JP (2) | JP7379347B2 (https=) |
| CN (1) | CN112105380A (https=) |
| WO (1) | WO2019075216A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102486507B1 (ko) | 2016-04-08 | 2023-01-09 | 아이티아이 헬스, 인크. | 플렉틴-1 결합 항체 및 그의 용도 |
| JP7379347B2 (ja) * | 2017-10-11 | 2023-11-14 | ジィールバイオ，インコーポレーテッド | プレクチン１結合抗体およびその使用 |
| GB202012761D0 (en) * | 2020-08-14 | 2020-09-30 | Univ Oxford Brookes | Metastatis treatment or prevention |
| US20250011418A1 (en) * | 2021-10-29 | 2025-01-09 | Zielbio, Inc. | Cancer specific plectin-1 specific antibodies and methods of use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US20040101874A1 (en) * | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
| US20050164324A1 (en) | 2003-06-04 | 2005-07-28 | Gygi Steven P. | Systems, methods and kits for characterizing phosphoproteomes |
| US7842466B1 (en) | 2005-09-16 | 2010-11-30 | Celera Corporation | Colon disease targets and uses thereof |
| US20090110680A1 (en) * | 2006-04-07 | 2009-04-30 | Stephanie Sieger | Combination of an anti ED-B fibronectin domain antibody and gemcitabine |
| JP2011501731A (ja) | 2007-09-10 | 2011-01-13 | ユニバーシティ オブ マサチューセッツ | ミトコンドリア標的化抗腫瘍剤 |
| WO2009079585A2 (en) | 2007-12-17 | 2009-06-25 | Dyax Corp. | Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| JP5497006B2 (ja) | 2008-04-14 | 2014-05-21 | ザ ジェネラル ホスピタル コーポレイション | 膵管腺癌の検出および治療のためのプレクチン−１標的化剤 |
| WO2011057078A2 (en) | 2009-11-05 | 2011-05-12 | University Of Virginia Patent Foundation | Compositions and methods for detecting plectin-1 as a biomarker for cancer |
| WO2014028668A2 (en) * | 2012-08-14 | 2014-02-20 | Minerva Biotechnologies Corporation | Stem cell enhancing therapeutics |
| US9856315B2 (en) | 2014-10-15 | 2018-01-02 | Cell Signaling Technology, Inc. | Methylation and acetylation sites |
| US10611796B2 (en) | 2016-03-16 | 2020-04-07 | Council Of Scientific & Industrial Research | Method for regressing pancreatic tumor by a liposomal formulation along with DNA vaccines |
| KR102486507B1 (ko) * | 2016-04-08 | 2023-01-09 | 아이티아이 헬스, 인크. | 플렉틴-1 결합 항체 및 그의 용도 |
| JP7379347B2 (ja) * | 2017-10-11 | 2023-11-14 | ジィールバイオ，インコーポレーテッド | プレクチン１結合抗体およびその使用 |
-
2018
- 2018-10-11 JP JP2020542037A patent/JP7379347B2/ja active Active
- 2018-10-11 WO PCT/US2018/055438 patent/WO2019075216A1/en not_active Ceased
- 2018-10-11 CN CN201880079957.6A patent/CN112105380A/zh active Pending
-
2020
- 2020-04-10 US US16/846,031 patent/US12053530B2/en active Active
-
2023
- 2023-08-04 JP JP2023127717A patent/JP2023155262A/ja active Pending